EarningsQ4 2023 Earnings Report

Innate Pharma SA (IDD) Q4 2023 Earnings Report

1 Followers

DE:IDD Q4 2023 EPS Results

Actual EPS-€0.12

Consensus EPS-€0.40

Beat/MissBeat by +€0.28

One Year Ago EPS-€0.81

Actual Revenue€16.56M

Expected Revenue€16.82M

Beat/MissMissed by -€264.00K

YoY Revenue Growth+99.27%

QuarterQ4 2023

Date03/21/2024

TimeBefore Open

Conference CallThursday, March 21, 2024

DE:IDD Upcoming Earnings

Innate Pharma SA's next earnings date is estimated for March 25, 2027, based on past reporting schedules.

DE:IDD Q4 2023 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Mar 25, 2027	2026 (Q4)	-0.25 / -	-0.31	―
Sep 17, 2026	2026 (Q2)	-0.16 / -0.21	-0.25	16.00% (+0.04)
Mar 26, 2026	2025 (Q4)	-0.12 / -0.31	-0.31	0.00% (0.00)
Sep 17, 2025	2025 (Q2)	-0.28 / -0.25	-0.31	19.35% (+0.06)
Mar 27, 2025	2024 (Q4)	-0.26 / -0.31	-0.12	-158.33% (-0.19)
Sep 12, 2024	2024 (Q2)	-0.28 / -0.31	0.02	-1650.00% (-0.33)
Mar 21, 2024	2023 (Q4)	-0.40 / -0.12	-0.81	85.19% (+0.69)
Sep 14, 2023	2023 (Q2)	0.08 / 0.02	0.08	-75.00% (-0.06)
Mar 23, 2023	2022 (Q4)	-0.39 / -0.81	-0.35	-131.43% (-0.46)
Sep 15, 2022	2022 (Q2)	0.33 / 0.08	-0.3	126.67% (+0.38)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed